Europe Approves Paroxysmal Nocturnal Hemoglobinuria Drug Europe Approves Paroxysmal Nocturnal Hemoglobinuria Drug
The factor D inhibitor danicopan has been approved for use in Europe for patients with paroxysmal nocturnal hemoglobinuria with residual hemolytic anemia on standard therapy.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 23, 2024 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Alert Source Type: news
GLP-1s Before Endoscopy: AGA Issues Clinical Practice Update GLP-1s Before Endoscopy: AGA Issues Clinical Practice Update
The update included background on the relationship between GLP-1 receptor agonists and endoscopic procedures, followed by clinical strategies for patients taking these medications.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 23, 2024 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
OUD Expert: How to Start Buprenorphine in Primary Care OUD Expert: How to Start Buprenorphine in Primary Care
Former obstacles are no longer an issue to prescribing the drug.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 23, 2024 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news
Vaccine-Preventable Diseases Surge: Europe Sounds the Alarm Vaccine-Preventable Diseases Surge: Europe Sounds the Alarm
ECDC data show that measles and pertussis cases are on the rise again after a post –COVID-19 pandemic decline.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 22, 2024 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
UK Drug Shortages Swell Amid Brexit Supply Woes, Think-tank Data Shows UK Drug Shortages Swell Amid Brexit Supply Woes, Think-tank Data Shows
Drug shortages in the UK more than doubled between 2020 and 2023 with Brexit likely to " significantly weaken " the country ' s ability to tackle supply chain snags, according...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 18, 2024 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news
GLP-1s May Increase Post-Endoscopy Aspiration Pneumonia Risk GLP-1s May Increase Post-Endoscopy Aspiration Pneumonia Risk
Although the overall incidence remains low, patients on GLP-1s have a 33% higher chance of aspiration pneumonia after endoscopic procedures, according to a new large population-based study.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 18, 2024 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
New Trial Deepens Debate Over Late-Preterm Steroids New Trial Deepens Debate Over Late-Preterm Steroids
Steroids can prevent neonatal respiratory distress in women at risk for delivery before 34 weeks, but their utility in women expected to deliver later in pregnancy but still preterm remains unclear.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 17, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
Can Thyroid Dysfunction Cause Hormonal Imbalance? Can Thyroid Dysfunction Cause Hormonal Imbalance?
When to suspect that thyroid dysfunction is responsible for a hormonal imbalance, and how to determine whether it is the cause.American Thyroid Association (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 16, 2024 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Commentary Source Type: news
Hormone Therapy After 65 Good Option for Most Women Hormone Therapy After 65 Good Option for Most Women
Many women have decided against hormone therapy, especially after age 65, because of fears of increased risks for cancers and heart disease.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 16, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
US Employers Must Accommodate Abortions, Birth Control, Agency Says US Employers Must Accommodate Abortions, Birth Control, Agency Says
U.S. employers ' obligation to accommodate workers ' pregnancies also extends to abortions and the use of contraception, the U.S. agency that enforces workplace discrimination...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news
DMARD Taper-to-Discontinuation Approach Increases Flare Risk DMARD Taper-to-Discontinuation Approach Increases Flare Risk
In two trials, most patients with RA in remission who tapered csDMARD or TNF inhibitor drugs to withdrawal experienced flares within 3 years.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2024 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
Alopecia Areata: Late Responses to JAK Inhibitors Reported Alopecia Areata: Late Responses to JAK Inhibitors Reported
Response curves have continued to climb for as long as patients are followed, allowing many with disappointing early results to catch up, according to data presented at the AAD meeting.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 15, 2024 Category: Drugs & Pharmacology Tags: Dermatology News Source Type: news
Bausch Wins US Appeal to Block Alvogen Generic Of Diarrhea Drug Bausch Wins US Appeal to Block Alvogen Generic Of Diarrhea Drug
A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch ' s diarrhea...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 11, 2024 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Lead's Lingering Threat: Water and More Pose Dangers Lead's Lingering Threat: Water and More Pose Dangers
New studies reveal lead in drinking water is still a problem, and clinicians may want to screen children for lead exposure.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 5, 2024 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care Source Type: news
CVS Caremark to Cover Perrigo's Birth Control Pill in US At Zero Cost for Plan Sponsors CVS Caremark to Cover Perrigo's Birth Control Pill in US At Zero Cost for Plan Sponsors
CVS Caremark, the pharmacy benefit management subsidiary of CVS Health Corp, will add Perrigo ' s birth control pill to its preventive services oral contraceptives list and...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 4, 2024 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health Source Type: news
